Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
| Autor: | Dodick, David W, Goadsby, Peter J, Spierings, Egilius L H, Scherer, Joel C, Sweeney, Steven P, Grayzel, David S |
|---|---|
| Zdroj: | In The Lancet Neurology September 2014 13(9):885-892 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|